Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

View:
Post by palinc2000 on Apr 27, 2021 5:54pm

Why?

Knowing what we know from a lot of studies in the last year on the high incidence of Nash on people with Hiv Why dont doctors prescribe Egrifta to ALL    Patients suffering from Lipo?Can FDA make such reccomandation?
Comment by jeffm34 on Apr 27, 2021 6:10pm
Early on Egrifta had a perception of being a "cosmetic" drug to help reduce belly fat.  Some of that perception may still persist.  It's up to TH to sell the other benefits to physicians.  Some physicians may be reluctant to prescribe based on cost/benefit if they don't see the whole picture. More importantly I think TH needs to do a lot of direct to patient ...more  
Comment by jeffm34 on Apr 27, 2021 6:13pm
Targeting specific patients is where a good social media campaign can come into play.
Comment by jeffm34 on Apr 27, 2021 6:52pm
There are lots of companies they can hire to do it for them. Pretty easy stuff.   https://www.stackadapt.com/industry-solutions/healthcare?utm_source=search&utm_medium=google
Comment by SPCEO1 on Apr 27, 2021 6:59pm
I would not be surprised if they wanted to hold back on doing a big Egrifta marketing effort until F8 was available. They also already tried a  social media campaign and a direct marketing effort. I suspect they did not work for long because the F1 was so nasty to use. The F4 is better but still a bit problematic. The F8 will be much easier to administer.
Comment by jeffm34 on Apr 27, 2021 7:39pm
they have a lot more compelling data they can use to sell it now 
Comment by qwerty22 on Apr 27, 2021 7:17pm
.... or tap into Paul's experience and get some return on the $2 mil
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities